TY - JOUR
TI - Response to: Comment on ‘Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines’
AU - Peris, K.
AU - Fargnoli, M.C.
AU - Garbe, C.
AU - Kaufmann, R.
AU - Bastholt, L.
AU - Seguin, N.B.
AU - Bataille, V.
AU - del Marmol, V.
AU - Dummer, R.
AU - Harwood, C.A.
AU - Hauschild, A.
AU - Höller, C.
AU - Haedersdal, M.
AU - Malvehy, J.
AU - Middleton, M.R.
AU - Morton, C.A.
AU - Nagore, E.
AU - Stratigos, A.J.
AU - Szeimies, R.-M.
AU - Tagliaferri, L.
AU - Trakatelli, M.
AU - Zalaudek, I.
AU - Eggermont, A.
AU - Grob, J.J.
AU - the European Dermatology Forum (EDF)
AU - the European Association of Dermato-Oncology (EADO)
AU - the European Organization for Research
AU - Treatment of Cancer (EORTC)
JO - EUROPEAN JOURNAL OF CANCER
PY - 2020
VL - 140
TODO - null
SP - 154-157
PB - Elsevier Ireland Ltd
SN - null
TODO - 10.1016/j.ejca.2020.08.006
TODO - antineoplastic agent, advanced cancer;  algorithm;  basal cell carcinoma;  cancer control;  cancer diagnosis;  cancer palliative therapy;  cancer recurrence;  cancer therapy;  clinical effectiveness;  clinical practice;  consensus;  electrochemotherapy;  Europe;  follow up;  human;  Kaposi sarcoma;  Letter;  merkel cell carcinoma;  multicenter study (topic);  observational study;  practice guideline;  priority journal;  prospective study;  recurrence risk;  retrospective study;  soft tissue sarcoma;  treatment response;  tumor volume;  basal cell carcinoma;  skin tumor, Carcinoma, Basal Cell;  Consensus;  Humans;  Skin Neoplasms
TODO - null
ER -